Bob Lederer RBDR

Online Brits not impacting brands. IBM Watson unleashed on research (RBDR 9/3/2014)

RBDR is sponsored by Curiosity InsightStream, a consumer insights company helping clients derive deep human insights through social media listening.

Find out detail about clients that have benefitted from working with Curiosity Insight Stream at: http://www.curiosityinsightstream.com/case_studies
Today on RBDR: 1) Kantar Media TGI’s study of British online users shows a very low correlation between their online presence and brand activity. 2) The 7th annual UMass Dartmouth Center for Marketing Research focused on Fortune 500 use of social media shows huge buy-in of new social media platforms. 3) IBM’s Watson is being unleashed in the scientific world to show possibilities between chemical compounds and help scientists sift through tends of thousands of daily releases of papers.

Bob Lederer RFL Communications, Inc.

Biotech’s 1st Chief Patient Officer; ACA boosts Medicaid Rx spend (PRVR–4/7 to 4/11/2014)

This week on Pharma Research VIDEO Report: 1) Pharmaceutical companies have cut back on what they pay physicians to speak on their behalf, but the real attention getter will be the searchable database patients will be able to access with 2013 data on pharmacy spending of $10 or more with each U.S. doctor. 2) Sanofi breaks new industry ground by appointing the first Chief Patient Officer. 3) Charlotte Sibley returns to recommend three steps that pharmaceutical companies can take with their research departments to implement Big Data opportunities. 4) With the ACA’s 2014 enrollment period in the past, the first reports of its impact on the pharmaceutical industry are being released.